Idera wins FDA green light for state of matter II psoriasis drug mental testing FierceBiotech The company conveyed the FDA an initial Phase II trial rule back in July, which would test the new dual-TLR antagonist in disease of the skin patients over 12 weeks of treatment. The government agency placed that plan connected hold over various concerns. ... FDA clears Idera psoriasis therapy trial medicine Business Review all vii news articles » Link To Article
No comments:
Post a Comment